FDAFDA · Food and drugs·Recall number D-0617-2023
Ceftriaxone for Injection, USP 500 mg per vial, Rx only, Manufactured for: Xellia Pharmaceuticals USA, LLC, Buffalo Grove, IL 60089, NDC 70594-095-02
Published May 24, 2023 · Recall initiated: May 15, 2023
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- Astral SteriTech Private Ltd.
- Distributor
- Nationwide within the United States
- Lot
- All lots within expiry.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.